Showing 5281-5290 of 7750 results for "".
- Kenvue’s Ricciardone Explains New Data on the Value of Teamwork in Moisturizers and Retinoidshttps://practicaldermatology.com/news/Kenvues-Ricciardone-Explains-New-Data-Value-Teamwork-Moisturizers-Retinoids/2474166/Data presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida, supported the “full sandwich” moisturizer method for new retinoid users who may experience sensitivity from retinization during the skin acclimation period while also suggesting that Neutrogena® H
- Researchers Identify Novel IL-17A-Linked Psoriasis Gene and Therapeutic Targethttps://practicaldermatology.com/news/plek-identified-as-novel-il-17a-linked-psoriasis-gene-and-therapeutic-target/2473942/Machine learning and in vivo experimentation have identified
- From Tattoos to Virtual Tools: A Look at the Technology Transforming Hair Clinicshttps://practicaldermatology.com/news/from-tattoos-to-virtual-tools-a-look-at-the-technology-transforming-hair-clinics/2471548/
- Promoting Pigmentation and Preventing Relapses Highlighted as Keys in Vitiligo Treatmenthttps://practicaldermatology.com/news/Promoting-Pigmentation-Preventing-Relapses-Highlighted-Keys-Vitiligo-Treatment/2471550/The way practitioners diagnose and manage vitiligo patients continues to advance with recent discoveries in the pathogenesis, risk factors, and features of the disease activity. At the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida, one discussion focused on pattern
- Exosomes for Hair Regrowth: Tech with Potentialhttps://practicaldermatology.com/news/exosomes-for-hair-regrowth-tech-with-potential/2471533/
- Beyond the Surface: Updates in Itch Treatmenthttps://practicaldermatology.com/news/beyond-the-surface-updates-in-itch-treatment/2471285/
- Bill Collection Made Tougher by Recent Changes in Credit Reportinghttps://practicaldermatology.com/news/Bill-Collection-Made-Tougher-Recent-Changes-Credit-Reporting/2471259/Americans owe $220 billion in medical debt,1 and the most effective method for collecting money could soon cease to be an option. Mark Nestor, MD, PhD, highlighted this issue during a presentation at the Winter Clinical Hawaii 2025 meeting in Waikoloa Village, Hawaii. “Ba
- Weight-Loss Drugs Highlighted as 'Easy' Option to Improve PsO Therapieshttps://practicaldermatology.com/news/Weight-Loss-Drugs-Highlighted-Easy-Option-Improve-PsO-Therapies/2471215/Any dermatologist not prescribing weight-loss drugs for psoriasis patients who are obese likely will be soon, according to Mark Lebwohl, MD. Dr. Lebwohl, speaking at the Winter Clinical Hawaii 2025 meeting in Waikoloa Village, Hawaii, highlighted data indicating an association between como
- Study: Safety Signals Emerge for IL-23 and IL-12/23 Inhibitors in Psoriasis Treatmenthttps://practicaldermatology.com/news/safety-signals-emerge-for-il-23-and-il-1223-inhibitors-in-psoriasis-treatment/2470971/A new analysis of psoriasis patients indicates an emergence of new safety signals associated with interleukin-23 (IL-23) inhibitors and the IL-12/23 inhibitor ustekinumab. Researchers on the study analyzed 41.4 million adverse event (AE) reports from the FDA Adverse Event Reporting System
- GW SMHS Teledermatology Program Receives Renewed Fundinghttps://practicaldermatology.com/news/gw-smhs-teledermatology-program-receives-renewed-funding/2468756/The George Washington University School of Medicine and Health Sciences Department of Dermatology, in collaboration with the Pennsylvania Avenue Baptist Church and the National Psoriasis Foundation (NPF), announced a renewed funding commitment of $350,000 from Johnson & Johnson in support of